Applicant: Hu Chunliang.
Application date: May 24th, 2006-Main classification number: A6 1K36/8968.
The invention discloses a Chinese patent medicine for regulating blood sugar, which contains effective parts of ginseng extracted by alcohol and total ginsenoside made from ethanol extracts of Scrophularia, Ophiopogon japonicus and Radix Rehmanniae, and the weight ratio is1:1. Uniformly mixing the two components at the weight ratio of 1: 2, and taking them as the effective components of the Chinese patent medicine for regulating blood sugar. Mixing with pharmaceutical adjuvants or excipients, and making into capsules, tablets, granules and pills. Can be used for preventing or treating diabetes, especially treating type 2 diabetes, and has good therapeutic effect.